Drive 110%+ NRR with churn prevention + expansion intelligence built on clinical diagnostic thinking.
Your churn prediction tool flags 10 accounts as at-risk.
Only 3 actually churn.
After enough false alarms, your team stops believing the alerts.
This is called alarm fatigue — and every CS leader we interviewed mentioned it.
15 / 15
CS leaders interviewed mentioned alarm fatigue unprompted
50–70%
Current tool accuracy — basically a coin flip
“When specialists investigate red flags only to find healthy accounts, they lose trust. They feel they’re putting in ‘useless effort.’”
The real problem? It’s not lack of data. It’s lack of trust. False positives destroy team adoption — and without trust, even accurate predictions become shelfware.
Discovery Complete · 15 Interviews · US, Europe, Brazil, Africa, Australia
Current accuracy baseline: 50–70% everywhere
From Melbourne to São Paulo to Lagos: same problem, same accuracy range.
Alarm fatigue is universal
False positives waste time, destroy trust, and break team adoption.
Operationalization > Prediction
“The challenge isn’t detecting risk — it’s knowing what to do about it.”
Wrong-fit is a GTM problem
“50% of churn is created at the point of sale — CS teams inherit the problem.”
Retention is table stakes. Expansion is the value.
“If a customer isn’t expanding, that’s already a churn signal.”
I spent 30 years as a physician. A good physician doesn’t say “you have a 73% chance of condition X.”
A good physician says:
“Here are the three signals I’m seeing,
here’s what they suggest,
here’s what I want to rule out,
and here’s what we do next.”
That’s how Samadly works.
Every Other Tool
"Customer X has 75% churn risk"
Signal → Action. No diagnosis.
Your team: "Schedule a call" — but why? About what?
Samadly
Customer X: $24,000 ARR at risk · 87% confidence
① SIGNAL:
Usage −43% · 3 support tickets · Exec sponsor inactive 47 days
② DIAGNOSIS:
Most likely: Executive disengagement (not training gap, not product fit issue — usage pattern rules those out). Matches 78% of churned accounts in this cohort.
③ DECISION OPTIONS:
A) Executive business review — high effort, high impact
B) ROI report to exec sponsor — low effort, medium impact
C) Escalate to account manager — if commercial risk
Most tools fail because they jump from signal to action. Samadly adds the layer that makes the difference.
What is happening — and how confident we are
Ingests product usage, support tickets, communication frequency, stakeholder engagement, and billing signals. Outputs signal type, strength, confidence score, and time horizon. Every CS tool has this layer. It is necessary but not sufficient.
What is actually wrong — the most important layer
Samadly's core moatApplies differential diagnosis to rule out alternative explanations before surfacing the most likely root cause. The same signal can mean training gap, value failure, stakeholder misalignment, or weak use case. Diagnosis determines which. This layer requires cross-company benchmark data and clinical methodology. No competitor has it.
What are the possible actions — and their trade-offs
Takes the confirmed diagnosis and surfaces 2–3 specific intervention options with effort level, impact probability, and time sensitivity. The CSM decides. Samadly advises with context. Expansion signal detection added Q3 2026.
Goal: 110%+ NRR, not just 100% retention.
VP Customer Success at B2B SaaS companies ($3–50M ARR)
Built For
You’re treating retention as a revenue discipline — not just a CS metric.
Not Built For
Maximum 50 Companies. By Design.
Diagnostic accuracy requires partnership, not automation at scale.
Excellence doesn’t scale infinitely. So we’re choosing depth over breadth.
March 2026
15 customer discovery interviews complete (5 continents)
April 2026
Foundation decisions
May–June 2026
Build + pilot onboarding
July–October 2026
Iterate + prove 85%+ accuracy
Q4 2026
Invitation-only expansion
We’re onboarding 3–5 pilot customers in May–June 2026.
What You Get
What We Need
Be among the first 50 companies when we expand beyond pilots.
Pilot spots are limited to 3–5 companies. If you’re not ready to commit to a pilot now, join the waitlist to be first in line for Q4 2026 expansion.
Questions? Email [email protected]
I spent 30 years managing hospitals and disease surveillance systems across entire regions of Ghana.
I've seen preventable deaths caused by disconnected data:
— Lab results in one clinic
— Imaging in another hospital
— Patient history somewhere else
— Each doctor seeing their piece
— Nobody connecting the dots until too late
When I moved into technology, I saw the exact same pattern in B2B SaaS. Customer signals scattered everywhere. Teams working in silos. Customers churning "out of nowhere."
Samadly is my answer to a question I couldn't unsee: How many preventable losses will we accept before we connect the dots?
Mission: Prevent disconnected data from causing preventable loss — in business today, in healthcare tomorrow.
No credit card required · We review every application personally
We’re building this in public. Every interview, every finding, every mistake — documented on LinkedIn. Follow the journey.
Pilot Customers
3–5 spots. May–June 2026. No cost. Full access.
Waitlist
Q4 2026 expansion. First 50 companies only.
Stay Updated
Building in public. Follow the journey.